Skip to content

CorMedix CRMD Book Value Of Raw Materials

Book Value Of Raw Materials at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.53M-0.2%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$490K
Mondelez International logo
Mondelez InternationalMDLZ
$981M-15.4%
Exxon Mobil logo
Exxon MobilXOM
$3.14B-21.1%
PPG Industries logo
PPG IndustriesPPG
$656M-3.7%
Raytheon Technologies logo
Raytheon TechnologiesRTX
$4.98B+10.8%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept crmd:BookValueOfRawMaterials.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's book value of raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's book value of raw materials?
CorMedix (CRMD) reported book value of raw materials of $0 in Q4 2025.
What does book value of raw materials mean?
The recorded cost of unprocessed inventory held by the company for use in the production of finished goods. This metric is a key indicator of supply chain readiness and the company's ability to meet future manufacturing demand.